0001181431-13-049523.txt : 20130917
0001181431-13-049523.hdr.sgml : 20130917
20130917173703
ACCESSION NUMBER: 0001181431-13-049523
CONFORMED SUBMISSION TYPE: 4
PUBLIC DOCUMENT COUNT: 1
CONFORMED PERIOD OF REPORT: 20130916
FILED AS OF DATE: 20130917
DATE AS OF CHANGE: 20130917
ISSUER:
COMPANY DATA:
COMPANY CONFORMED NAME: Sagent Pharmaceuticals, Inc.
CENTRAL INDEX KEY: 0001369786
STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834]
IRS NUMBER: 000000000
STATE OF INCORPORATION: DE
BUSINESS ADDRESS:
STREET 1: 1901 NORTH ROSELLE ROAD, SUITE 700
CITY: SCHAUMBURG
STATE: IL
ZIP: 60195
BUSINESS PHONE: 847-908-1604
MAIL ADDRESS:
STREET 1: 1901 NORTH ROSELLE ROAD, SUITE 700
CITY: SCHAUMBURG
STATE: IL
ZIP: 60195
FORMER COMPANY:
FORMER CONFORMED NAME: Sagent Holding Co.
DATE OF NAME CHANGE: 20090529
FORMER COMPANY:
FORMER CONFORMED NAME: NHS PHARMACEUTICALS
DATE OF NAME CHANGE: 20060720
REPORTING-OWNER:
OWNER DATA:
COMPANY CONFORMED NAME: YORDON JEFFREY
CENTRAL INDEX KEY: 0001189013
FILING VALUES:
FORM TYPE: 4
SEC ACT: 1934 Act
SEC FILE NUMBER: 001-35144
FILM NUMBER: 131102182
4
1
rrd390716.xml
X0306
4
2013-09-16
0
0001369786
Sagent Pharmaceuticals, Inc.
SGNT
0001189013
YORDON JEFFREY
C/O SAGENT PHARMACEUTICALS, INC.
1901 NORTH ROSELLE ROAD, SUITE 700
SCHAUMBURG
IL
60195
1
1
0
0
Chief Executive Officer
Common Stock
2013-09-16
4
S
0
85813
20.0282
D
669036
D
In connection with Sagent Pharmaceutical, Inc.'s (the "Issuer") registered offering, Jeffrey Yordon sold 85,813 shares of the Issuer's common stock, pursuant to an underwriting agreement, dated September 10, 2013, by and among the Issuer, the underwriters and the selling stockholders party thereto.
Mr. Yordon's shares were sold at a price of $20.0282 per share, which is the price to the public ($21.25 per share) less the underwriting discounts and commissions ($1.2218 per share).
/s/ Jeffrey Yordon
2013-09-17